Status:
COMPLETED
The Effect Site Concentration of Remifentanil for Preventing QTc Interval Prolongation During Intubation in Normotensive and Hypertensive Patients
Lead Sponsor:
Severance Hospital
Conditions:
Intubation, Intratracheal
Eligibility:
FEMALE
50+ years
Phase:
NA
Brief Summary
To find out the effect site concentration of remifentanil for preventing QTc interval prolongation during intubation under propofol-remifentanil anesthesia in normotensive and hypertensive patients
Detailed Description
It is known that anesthetic agents can influence the QTc. In addition, tracheal intubation during induction can stimulates sympathetic activity, which, as a results, prolong the QTc interval. Therefor...
Eligibility Criteria
Inclusion
- ≥ 50 years ASA class I-II female who received surgery with endotracheal intubation
Exclusion
- emergency surgery electrocardiography abnormality diabetes mellitus end stage renal disease moderate to severe cardiac disease moderate to severe liver dysfunction
Key Trial Info
Start Date :
June 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2014
Estimated Enrollment :
44 Patients enrolled
Trial Details
Trial ID
NCT01880931
Start Date
June 1 2013
End Date
November 1 2014
Last Update
April 9 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Anesthesiology and Pain Medicine and Anesthesia and Pain Research Institute, Yonsei University College of Medicine
Seoul, South Korea